Only those with emotional attachment to this stock will welcome...

First 22101 Last

Share
Profile

Follow
Kaeho

6,951 Posts.

1628

02/04/24

15:00

Post #: 73150248
Share

Originally posted by Sdaji: ↑

At the current rate of cash burn there will be insufficient funds to keep the lights beyond about the quarter after next. It is now near enough that we can pretty safely say that we are not going to see the plant suddenly start pumping out a large amount of product and for sales to be bringing in significant revenue before that time comes. Currently the total inventory of product, if sold successfully at current market prices, would provide enough funds to keep the lights on for a few extra weeks or so.

Companies are basically never stupid enough to wait until the last minute before cash runs out before going through with a CR as this results in severe harm and dilution and sometimes runs the risk of insolvency or defaulting on payments causing various types of significant harm if the CR doesn't go through smoothly. The later they leave it the more the market wakes up to the upcoming necessity causing a price drop in anticipation meaning the CR must be done at a lower price. Generally if a CR is going to be required the company tries to surprise the market with the trading halt to avoid a preemptive selloff (though the resulting selloff is unavoidable).

All this together means it's likely that the next piece of significant news we get from AGY is likely to be a CR trading halt. Given the current price of around 13c, the constant delays and disappointments and complete lack of revenue, the CR price would presumably be below 10c if they did it now and the price would then sink to significantly below that price. Go look at other CRs, this is typical for a 'keeping the lights on' CR, and even in a 'raising funds for an exciting new project' scenario CR the price would be sub 10c at a typical CR discount, especially given it is to produce a third plant after the first two have so far failed to get to even around 5% of nameplate even after years of delays - the more speculative the project the greater the discount.

At this point it is a very long way beyond the point where anyone could think there is any chance of funding a 10,000TPA plant from organic revenue, so raising external funds for an expansion is a guarantee. We are all but at the point where we can guarantee a 'keeping the lights' CR is inevitable, but even if you don't think it's certain, if you actually go through the numbers you'd have to admit it's at least a pretty safe bet, and I doubt you could find anyone who would argue when I say that the CR would definitely drop the share price.

Putting all this together it's puzzling to see what you would want to be holding at the moment. I dumped some of my shares last year but was waiting for an exit before the CR for a few months and was very pleased to get the price I did last month.

Expand

Only those with emotional attachment to this stock will welcome a CR at lowball prices instead of questioning where the imminent deal has gone….

AGY Price at posting: 13.0¢ Sentiment: None Disclosure: Held
5 Upvote

1 Great analysis

Reply

There are more pages in this discussion • 446 more messages in this thread...

First 22101 Last

Add AGY (ASX) to my watchlist

(20min delay)
Last 13.0¢		Change 0.000(0.00%)		Mkt cap ! $182.5M

Open	High	Low	Value	Volume
13.0¢	13.5¢	12.5¢	$243.3K	1.864M

Buyers (Bids)

No.	Vol.	Price($)
12	702866	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.0¢	180922	2

View Market Depth

No.	Vol.	Price($)
12	702866	0.125
40	1534987	0.120
15	1137982	0.115
13	663228	0.110
9	734142	0.105

Price($)	Vol.	No.
0.130	180922	2
0.135	571321	17
0.140	668360	13
0.145	820968	11
0.150	809286	20

Last trade - 16.10pm 15/05/2024 (20 minute delay)


Last 12.5¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
13.0¢	13.5¢	12.5¢	700008
Last updated 15.59pm 15/05/2024 ?

AGY (ASX) Chart

Only those with emotional attachment to this stock will welcome...

Featured News

Recce Pharma heading closer to full efficacy data for flagship R327

Want copper with that? Boss Energy hits orange metal on-site uranium play

Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management

Market Close: Materials win on critical minerals, hydrogen budget promises

Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing

Buyers (Bids)

Sellers (Offers)

Featured News

Only those with emotional attachment to this stock will welcome...

Featured News

Top Stories

Recce Pharma heading closer to full efficacy data for flagship R327

Want copper with that? Boss Energy hits orange metal on-site uranium play

Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management

Market Close: Materials win on critical minerals, hydrogen budget promises

Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing

Buyers (Bids)

Sellers (Offers)

Featured News